{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:34:55Z","timestamp":1778916895658,"version":"3.51.4"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Headache Federation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s10194-018-0893-8","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T12:45:55Z","timestamp":1533645955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["PACAP38 and PAC1 receptor blockade: a new target for headache?"],"prefix":"10.1186","volume":"19","author":[{"name":"On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2912-3632","authenticated-orcid":false,"given":"Eloisa","family":"Rubio-Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvige","family":"Correnti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Deen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Kelderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Papetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"issue":"1","key":"893_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","volume":"164","author":"A Miyata","year":"1989","unstructured":"Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164(1):567\u2013574 \n                    https:\/\/doi.org\/10.1016\/0006-291X(89)91757-9","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"893_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0006-291X(90)92140-U","volume":"170","author":"A Miyata","year":"1990","unstructured":"Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170(2):643\u2013648 \n                    https:\/\/doi.org\/10.1016\/0006-291X(90)92140-U","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"893_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0006-291X(90)91914-E","volume":"166","author":"C Kimura","year":"1990","unstructured":"Kimura C, Ohkubo S, Ogi K, Hosoya M, Itoh Y, Onda H, Miyata A, Jiang L, Dahl RR, Stibbs HH, Arimura A, Fujino M (1990) A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem Biophys Res Commun 166(1):81\u201389 \n                    https:\/\/doi.org\/10.1016\/0006-291X(90)91914-E","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"893_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166(1):4\u201317. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01871.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"893_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0306-4522(01)00479-1","volume":"110","author":"K Shinohara","year":"2002","unstructured":"Shinohara K, Funabashi T, Nakamura TJ, Mitsushima D, Kimura F (2002) Differential regulation of pituitary adenylate cyclase-activating peptide receptor variants in the rat suprachiasmatic nucleus. Neuroscience 110(2):301\u2013308 \n                    https:\/\/doi.org\/10.1016\/S0306-4522(01)00479-1","journal-title":"Neuroscience"},{"issue":"1","key":"893_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/bst0230133","volume":"23","author":"L Joumot","year":"1995","unstructured":"Joumot L, Waeber C, Pantaloni C, Holsboer F, Seeburg PH, Bockaert J, Spengler D (1995) Differential signal transduction by six splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor. Biochem Soc Trans 23(1):133\u2013137. \n                    https:\/\/doi.org\/10.1042\/bst0230133","journal-title":"Biochem Soc Trans"},{"issue":"36","key":"893_CR7","doi-asserted-by":"publisher","first-page":"22146","DOI":"10.1074\/jbc.271.36.22146","volume":"271","author":"C Pantaloni","year":"1996","unstructured":"Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, Journot L (1996) Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 271(36):22146\u201322151. \n                    https:\/\/doi.org\/10.1074\/jbc.271.36.22146","journal-title":"J Biol Chem"},{"issue":"50","key":"893_CR8","doi-asserted-by":"publisher","first-page":"32226","DOI":"10.1074\/jbc.271.50.32226","volume":"271","author":"TK Chatterjee","year":"1996","unstructured":"Chatterjee TK, Sharma RV, Fisher RA (1996) Molecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channels. J Biol Chem 271(50):32226\u201332232. \n                    https:\/\/doi.org\/10.1074\/jbc.271.50.32226","journal-title":"J Biol Chem"},{"issue":"2","key":"893_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.mcn.2005.09.008","volume":"31","author":"EM Lutz","year":"2006","unstructured":"Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R (2006) Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol Cell Neurosci 31(2):193\u2013209 \n                    https:\/\/doi.org\/10.1016\/j.mcn.2005.09.008","journal-title":"Mol Cell Neurosci"},{"issue":"12","key":"893_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1046\/j.1365-2826.1999.00411.x","volume":"11","author":"FM Dautzenberg","year":"1999","unstructured":"Dautzenberg FM, Mevenkamp G, Wille S, Hauger RL (1999) N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding\/selectivity determinants. J Neuroendocrinol 11(12):941\u2013949. \n                    https:\/\/doi.org\/10.1046\/j.1365-2826.1999.00411.x","journal-title":"J Neuroendocrinol"},{"issue":"29","key":"893_CR11","doi-asserted-by":"publisher","first-page":"17267","DOI":"10.1074\/jbc.271.29.17267","volume":"271","author":"JR Pisegna","year":"1996","unstructured":"Pisegna JR, Wank SA (1996) Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor: evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem 271(29):17267\u201317274. \n                    https:\/\/doi.org\/10.1074\/jbc.271.29.17267","journal-title":"J Biol Chem"},{"key":"893_CR12","doi-asserted-by":"crossref","unstructured":"Blechman J, Levkowitz G (2013) Alternative splicing of the pituitary adenylate cyclase-activating polypeptide receptor PAC1: mechanisms of fine tuning of brain activity. Front Endocrinol 4(55):1\u201319","DOI":"10.3389\/fendo.2013.00055"},{"issue":"3","key":"893_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","volume":"121","author":"L Dickson","year":"2009","unstructured":"Dickson L, Finlayson K (2009) VPAC and PAC receptors: from ligands to function. Pharmacol Ther 121(3):294\u2013316 \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2008.11.006","journal-title":"Pharmacol Ther"},{"key":"893_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/365170a0","volume":"365","author":"D Spengler","year":"1993","unstructured":"Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburgt PH, Journot L (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170. \n                    https:\/\/doi.org\/10.1038\/365170a0","journal-title":"Nature"},{"issue":"39","key":"893_CR15","doi-asserted-by":"publisher","first-page":"27702","DOI":"10.1074\/jbc.274.39.27702","volume":"274","author":"KM Braas","year":"1999","unstructured":"Braas KM, May V (1999) Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC1 receptor isoform activation of specific intracellular signaling pathways. J Biol Chem 274(39):27702\u201327710. \n                    https:\/\/doi.org\/10.1074\/jbc.274.39.27702","journal-title":"J Biol Chem"},{"issue":"2","key":"893_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.npep.2012.12.005","volume":"47","author":"A Erdling","year":"2013","unstructured":"Erdling A, Sheykhzade M, Maddahi A, Bari F, Edvinsson L (2013) VIP\/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium. Neuropeptides 47(2):85\u201392. \n                    https:\/\/doi.org\/10.1016\/j.npep.2012.12.005","journal-title":"Neuropeptides"},{"issue":"3","key":"893_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12031-012-9851-0","volume":"48","author":"AU Syed","year":"2012","unstructured":"Syed AU, Koide M, Braas KM, May V, Wellman GC (2012) Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine. J Mol Neurosci 48(3):574\u2013583. \n                    https:\/\/doi.org\/10.1007\/s12031-012-9851-0","journal-title":"J Mol Neurosci"},{"issue":"2","key":"893_CR18","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1074\/jbc.272.2.966","volume":"272","author":"O Moro","year":"1997","unstructured":"Moro O, Lerner EA (1997) Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J Biol Chem 272(2):966\u2013970. \n                    https:\/\/doi.org\/10.1074\/jbc.272.2.966","journal-title":"J Biol Chem"},{"issue":"1","key":"893_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0006-8993(00)03126-7","volume":"889","author":"I Tatsuno","year":"2001","unstructured":"Tatsuno I, Uchida D, Tanaka T, Saeki N, Hirai A, Saito Y, Moro O, Tajima M (2001) Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP\/VIP family receptors in cultured rat cortical neurons. Brain Res 889(1):138\u2013148 \n                    https:\/\/doi.org\/10.1016\/S0006-8993(00)03126-7","journal-title":"Brain Res"},{"issue":"1","key":"893_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1749-6632.1998.tb11185.x","volume":"865","author":"D Uchida","year":"1998","unstructured":"Uchida D, Tatsuno I, Tanaka T, Hirai A, Saito Y, Moro O, Tajima M (1998) Maxadilan is a specific agonist and its deleted peptide (M65) is a specific antagonist for PACAP type 1 receptor. Ann N Y Acad Sci 865(1):253\u2013258. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb11185.x","journal-title":"Ann N Y Acad Sci"},{"key":"893_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neuroscience.2015.08.043","volume":"308","author":"\u00c9 S\u00e1ghy","year":"2015","unstructured":"S\u00e1ghy \u00c9, Payrits M, Helyes Z, Regl\u0151di D, B\u00e1nki E, T\u00f3th G, Couvineau A, Sz\u0151ke \u00c9 (2015) Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons. Neuroscience 308:144\u2013156 \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2015.08.043","journal-title":"Neuroscience"},{"issue":"1","key":"893_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12031-008-9089-z","volume":"36","author":"D Reglodi","year":"2008","unstructured":"Reglodi D, Borzsei R, Bagoly T, Boronkai A, Racz B, Tamas A, Kiss P, Horvath G, Brubel R, Nemeth J, Toth G, Helyes Z (2008) Agonistic behavior of PACAP6-38 on sensory nerve terminals and Cytotrophoblast cells. J Mol Neurosci 36(1):270\u2013278. \n                    https:\/\/doi.org\/10.1007\/s12031-008-9089-z","journal-title":"J Mol Neurosci"},{"issue":"3","key":"893_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BKC, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61(3):283\u2013357. \n                    https:\/\/doi.org\/10.1124\/pr.109.001370","journal-title":"Pharmacol Rev"},{"issue":"6","key":"893_CR24","first-page":"619","volume":"21","author":"NM Sherwood","year":"2000","unstructured":"Sherwood NM, Krueckl SL, McRory JE (2000) The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)\/glucagon superfamily*. Endocr Rev 21(6):619\u2013670","journal-title":"Endocr Rev"},{"issue":"2","key":"893_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000125864","volume":"54","author":"K K\u00f6ves","year":"1991","unstructured":"K\u00f6ves K, Arimura A, G\u00f6rcs TG, Somogyv\u00e1ri-Vigh A (1991) Comparative distribution of Immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology 54(2):159\u2013169","journal-title":"Neuroendocrinology"},{"issue":"1","key":"893_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1210\/endo-127-1-264","volume":"127","author":"K K\u00f3ves","year":"1990","unstructured":"K\u00f3ves K, Arimura A, Somogyv\u00e1ri-Vigh A, Vigh S, Miller JIM (1990) Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus*. Endocrinology 127(1):264\u2013271","journal-title":"Endocrinology"},{"issue":"4","key":"893_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/cne.10418","volume":"453","author":"J Hannibal","year":"2002","unstructured":"Hannibal J (2002) Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 453(4):389\u2013417. \n                    https:\/\/doi.org\/10.1002\/cne.10418","journal-title":"J Comp Neurol"},{"issue":"1","key":"893_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0891-0618(92)90036-P","volume":"5","author":"L Kivipelto","year":"1992","unstructured":"Kivipelto L, Absood A, Arimura A, Sundler F, H\u00e5kanson R, Panula P (1992) The distribution of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity is distinct from helodermin- and helospectin-like immunoreactivities in the rat brain. J Chem Neuroanat 5(1):85\u201394 \n                    https:\/\/doi.org\/10.1016\/0891-0618(92)90036-P","journal-title":"J Chem Neuroanat"},{"issue":"4","key":"893_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/cne.20231","volume":"476","author":"KM Joo","year":"2004","unstructured":"Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI (2004) Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol 476(4):388\u2013413. \n                    https:\/\/doi.org\/10.1002\/cne.20231","journal-title":"J Comp Neurol"},{"issue":"1","key":"893_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0304-3940(94)90620-3","volume":"171","author":"JD Mikkelsen","year":"1994","unstructured":"Mikkelsen JD, Hannibal J, Larsen PJ, Fahrenkrug J (1994) Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex. Neurosci Lett 171(1):121\u2013124 \n                    https:\/\/doi.org\/10.1016\/0304-3940(94)90620-3","journal-title":"Neurosci Lett"},{"issue":"5","key":"893_CR31","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1210\/jcem-72-5-958","volume":"72","author":"K Suda","year":"1991","unstructured":"Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR (1991) Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by Radioligand binding and chemical cross-linking. J Clin Endocrinol Metabol 72(5):958\u2013964","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"893_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1677\/JOE-07-0125","volume":"195","author":"K Kageyama","year":"2007","unstructured":"Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T (2007) Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J Endocrinol 195(2):199\u2013211. \n                    https:\/\/doi.org\/10.1677\/joe-07-0125","journal-title":"J Endocrinol"},{"issue":"10","key":"893_CR33","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1210\/endo.138.10.5427","volume":"138","author":"M Nomura","year":"1997","unstructured":"Nomura M, Ueta Y, Larsen PJ, Hannibal J, Serino R, Kabashima N, Shibuya I, Yamashita H (1997) Water deprivation increases the expression of pituitary adenylate cyclase-activating polypeptide gene in the rat Subfornical organ*. Endocrinology 138(10):4096\u20134100","journal-title":"Endocrinology"},{"issue":"8","key":"893_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2826.1998.00244.x","volume":"10","author":"Y Mizuno","year":"1998","unstructured":"Mizuno Y, Kondo K, Terashima Y, Arima H, Murase T, Oiso Y (1998) Anorectic effect of pituitary adenylate cyclase activating polypeptide (PACAP) in rats: lack of evidence for involvement of hypothalamic neuropeptide gene expression. J Neuroendocrinol 10(8):611\u2013616. \n                    https:\/\/doi.org\/10.1046\/j.1365-2826.1998.00244.x","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"893_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroscience.2006.07.022","volume":"143","author":"L Mounien","year":"2006","unstructured":"Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, J\u00e9gou S (2006) Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience 143(1):155\u2013163 \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2006.07.022","journal-title":"Neuroscience"},{"key":"893_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/npp.2008.73","volume":"34","author":"L Mounien","year":"2008","unstructured":"Mounien L, Do Rego J-C, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, J\u00e9gou S (2008) Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic Melanocortin system. Neuropsychopharmacology 34:424. \n                    https:\/\/doi.org\/10.1038\/npp.2008.73","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"893_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbrc.2003.09.004","volume":"310","author":"C Kawaguchi","year":"2003","unstructured":"Kawaguchi C, Tanaka K, Isojima Y, Shintani N, Hashimoto H, Baba A, Nagai K (2003) Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem Biophys Res Commun 310(1):169\u2013175 \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2003.09.004","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"893_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00441-004-0858-x","volume":"316","author":"J Hannibal","year":"2004","unstructured":"Hannibal J, Fahrenkrug J (2004) Target areas innervated by PACAP-immunoreactive retinal ganglion cells. Cell Tissue Res 316(1):99\u2013113. \n                    https:\/\/doi.org\/10.1007\/s00441-004-0858-x","journal-title":"Cell Tissue Res"},{"issue":"13","key":"893_CR39","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1523\/JNEUROSCI.21-13-04883.2001","volume":"21","author":"J Hannibal","year":"2001","unstructured":"Hannibal J, Jamen F, Nielsen HS, Journot L, Brabet P, Fahrenkrug J (2001) Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor. J Neurosci 21(13):4883\u20134890","journal-title":"J Neurosci"},{"issue":"11","key":"893_CR40","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1210\/me.2004-0387","volume":"19","author":"EM Apostolakis","year":"2005","unstructured":"Apostolakis EM, Riherd DN, O\u2019Malley BW (2005) PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats. Mol Endocrinol 19(11):2798\u20132811","journal-title":"Mol Endocrinol"},{"issue":"1","key":"893_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0167-0115(02)00169-6","volume":"109","author":"N Shintani","year":"2002","unstructured":"Shintani N, Mori W, Hashimoto H, Imai M, Tanaka K, Tomimoto S, Hirose M, Kawaguchi C, Baba A (2002) Defects in reproductive functions in PACAP-deficient female mice. Regul Pept 109(1):45\u201348 \n                    https:\/\/doi.org\/10.1016\/S0167-0115(02)00169-6","journal-title":"Regul Pept"},{"issue":"2","key":"893_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuron.2011.11.019","volume":"73","author":"L Amir-Zilberstein","year":"2012","unstructured":"Amir-Zilberstein L, Blechman J, Sztainberg Y, Norton William HJ, Reuveny A, Borodovsky N, Tahor M, Bonkowsky Joshua L, Bally-Cuif L, Chen A, Levkowitz G (2012) Homeodomain protein Otp and activity-dependent splicing modulate neuronal adaptation to stress. Neuron 73(2):279\u2013291 \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.11.019","journal-title":"Neuron"},{"issue":"15","key":"893_CR43","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1523\/JNEUROSCI.21-15-05520.2001","volume":"21","author":"C Otto","year":"2001","unstructured":"Otto C, Kovalchuk Y, Wolfer DP, Gass P, Martin M, Zuschratter W, Gr\u00f6ne HJ, Kellendonk C, Tronche F, Maldonado R, Lipp H-P, Konnerth A, Sch\u00fctz G (2001) Impairment of mossy Fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J Neurosci 21(15):5520\u20135527. \n                    https:\/\/doi.org\/10.1523\/jneurosci.21-15-05520.2001","journal-title":"J Neurosci"},{"issue":"4","key":"893_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jphs.2016.01.008","volume":"130","author":"T Ohnou","year":"2016","unstructured":"Ohnou T, Yokai M, Kurihara T, Hasegawa-Moriyama M, Shimizu T, Inoue K, Kambe Y, Kanmura Y, Miyata A (2016) Pituitary adenylate cyclase-activating polypeptide type 1 receptor signaling evokes long-lasting nociceptive behaviors through the activation of spinal astrocytes in mice. J Pharmacol Sci 130(4):194\u2013203 \n                    https:\/\/doi.org\/10.1016\/j.jphs.2016.01.008","journal-title":"J Pharmacol Sci"},{"issue":"23","key":"893_CR45","doi-asserted-by":"publisher","first-page":"13355","DOI":"10.1073\/pnas.231094498","volume":"98","author":"H Hashimoto","year":"2001","unstructured":"Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, Sakaue M, J-i M, Niwa H, Tashiro F, Yamamoto K, Koga K, Tomimoto S, Kunugi A, Suetake S, Baba A (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci 98(23):13355\u201313360. \n                    https:\/\/doi.org\/10.1073\/pnas.231094498","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"893_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/j.1468-2982.2001.00140.x","volume":"21","author":"J Tajti","year":"2001","unstructured":"Tajti J, Uddman R, Edvinsson L (2001) Neuropeptide localization in the \u2018migraine generator\u2019 region of the human brainstem. Cephalalgia 21(2):96\u2013101. \n                    https:\/\/doi.org\/10.1046\/j.1468-2982.2001.00140.x","journal-title":"Cephalalgia"},{"issue":"4","key":"893_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00001756-200203250-00030","volume":"13","author":"M Knutsson","year":"2002","unstructured":"Knutsson M, Edvinsson L (2002) Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. NeuroReport 13(4):507\u2013509","journal-title":"NeuroReport"},{"issue":"20","key":"893_CR48","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1523\/JNEUROSCI.0439-13.2013","volume":"33","author":"C Robert","year":"2013","unstructured":"Robert C, Bourgeais L, Arreto CD, Condes-Lara M, Noseda R, Jay T, Villanueva L (2013) Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches. J Neurosci 33(20):8827\u20138840. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0439-13.2013","journal-title":"J Neurosci"},{"key":"893_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","volume":"1600","author":"S Eftekhari","year":"2015","unstructured":"Eftekhari S, Salvatore CA, Johansson S, Chen TB, Zeng Z, Edvinsson L (2015) Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier. Brain Res 1600:93\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2014.11.031","journal-title":"Brain Res"},{"issue":"1","key":"893_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4142\/jvs.2005.6.1.1","volume":"6","author":"P-O Koh","year":"2005","unstructured":"Koh P-O, Won C-K, Noh H-S, Cho G-J, Choi W-S (2005) Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta. J Vet Sci 6(1):1\u20135","journal-title":"J Vet Sci"},{"issue":"3","key":"893_CR51","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1210\/endo.141.3.7346","volume":"141","author":"ML Scaldaferri","year":"2000","unstructured":"Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C (2000) Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta*. Endocrinology 141(3):1158\u20131167. \n                    https:\/\/doi.org\/10.1210\/endo.141.3.7346","journal-title":"Endocrinology"},{"issue":"1","key":"893_CR52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/joe.1.06470","volume":"191","author":"S Vaccari","year":"2006","unstructured":"Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R (2006) Characterization and expression of different pituitary adenylate cyclase-activating polypeptide\/vasoactive intestinal polypeptide receptors in rat ovarian follicles. J Endocrinol 191(1):287\u2013299. \n                    https:\/\/doi.org\/10.1677\/joe.1.06470","journal-title":"J Endocrinol"},{"issue":"1","key":"893_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mrd.10221","volume":"64","author":"PO Koh","year":"2003","unstructured":"Koh PO, Kwak SD, Kim HJ, Roh G, Kim JH, Kang SS, Choi WS, Cho GJ (2003) Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta. Mol Reprod Dev 64(1):27\u201331. \n                    https:\/\/doi.org\/10.1002\/mrd.10221","journal-title":"Mol Reprod Dev"},{"issue":"2","key":"893_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0167-0115(02)00107-6","volume":"108","author":"G Guidone","year":"2002","unstructured":"Guidone G, M\u00fcller D, Vogt K, Mukhopadhyay AK (2002) Characterization of VIP and PACAP receptors in cultured rat penis corpus cavernosum smooth muscle cells and their interaction with guanylate cyclase-B receptors. Regul Pept 108(2):63\u201372 \n                    https:\/\/doi.org\/10.1016\/S0167-0115(02)00107-6","journal-title":"Regul Pept"},{"issue":"1","key":"893_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1385\/ENDO:23:1:59","volume":"23","author":"M Li","year":"2004","unstructured":"Li M, Funahashi H, Mbikay M, Shioda S, Arimura A (2004) Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells. Endocrine 23(1):59\u201375. \n                    https:\/\/doi.org\/10.1385\/endo:23:1:59","journal-title":"Endocrine"},{"issue":"6","key":"893_CR56","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1210\/jcem.87.6.8571","volume":"87","author":"G Mazzocchi","year":"2002","unstructured":"Mazzocchi G, Malendowicz LK, Rebuffat P, Gottardo L, Nussdorfer GG (2002) Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland. J Clin Endocrinol Metabol 87(6):2575\u20132580","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"893_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0167-0115(02)00295-1","volume":"113","author":"GM Portela-Gomes","year":"2003","unstructured":"Portela-Gomes GM, Lukinius A, Ljungberg O, Efendic S, Ahr\u00e9n B, Abdel-Halim SM (2003) PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas: evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets. Regul Pept 113(1):31\u201339 \n                    https:\/\/doi.org\/10.1016\/S0167-0115(02)00295-1","journal-title":"Regul Pept"},{"key":"893_CR58","doi-asserted-by":"crossref","unstructured":"Girard BM, Tooke K, Vizzard MA (2017) PACAP\/receptor system in urinary bladder dysfunction and pelvic pain following urinary bladder inflammation or stress. Front Syst Neurosci 11(90):1\u201323","DOI":"10.3389\/fnsys.2017.00090"},{"issue":"1","key":"893_CR59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000236498","volume":"101","author":"A Luts","year":"1993","unstructured":"Luts A, Uddman R, Alm R, Basterra J, Sundler F (1993) Peptide-containing nerve fibers in human airways: distribution and coexistence pattern. Int Arch Allergy Immunol 101(1):52\u201360","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"893_CR60","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0306-4522(92)90064-9","volume":"46","author":"F Sundler","year":"1992","unstructured":"Sundler F, Ekblad E, Absood A, H\u00e5kanson R, K\u00f6ves K, Arimura A (1992) Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience 46(2):439\u2013454 \n                    https:\/\/doi.org\/10.1016\/0306-4522(92)90064-9","journal-title":"Neuroscience"},{"issue":"3","key":"893_CR61","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000067180","volume":"10","author":"C Abad","year":"2002","unstructured":"Abad C, Martinez C, Leceta J, Juarranz MG, Delgado M, Gomariz RP (2002) Pituitary adenylate-cyclase-activating polypeptide expression in the immune system. Neuroimmunomodulation 10(3):177\u2013186","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"893_CR62","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1196\/annals.1317.085","volume":"1070","author":"N Tokuda","year":"2006","unstructured":"Tokuda N, Arudchelvan Y, Sawada T, Adachi Y, Fukumoto T, Yasuda M, Sumida H, Shioda S, Fukuda T, Arima A, Kubota S (2006) PACAP receptor (PAC1-R) expression in rat and rhesus monkey Thymus. Ann N Y Acad Sci 1070(1):581\u2013585. \n                    https:\/\/doi.org\/10.1196\/annals.1317.085","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"893_CR63","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1111\/j.1476-5381.1995.tb15939.x","volume":"116","author":"L Ny","year":"1995","unstructured":"Ny L, Larsson B, Alm P, Ekstr\u00f6m P, Fahrenkrug J, Hannibal J, Andersson KE (1995) Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter. Br J Pharmacol 116(7):2873\u20132880","journal-title":"Br J Pharmacol"},{"issue":"6","key":"893_CR64","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/sj.bjp.0700992","volume":"120","author":"O Cardell Lars","year":"1997","unstructured":"Cardell Lars O, Hjert O, Uddman R (1997) The induction of nitric oxide-mediated relaxation of human isolated pulmonary arteries by PACAP. Br J Pharmacol 120(6):1096\u20131100. \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0700992","journal-title":"Br J Pharmacol"},{"issue":"6","key":"893_CR65","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/01.WCB.0000121234.42748.F6","volume":"24","author":"F Martin","year":"2004","unstructured":"Martin F, Baeres M, M\u00f8ller M (2004) Origin of PACAP-immunoreactive nerve fibers innervating the Subarachnoidal blood vessels of the rat brain. J Cereb Blood Flow Metab 24(6):628\u2013635. \n                    https:\/\/doi.org\/10.1097\/01.wcb.0000121234.42748.f6","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"893_CR66","first-page":"3093","volume":"82","author":"K Filipsson","year":"1997","unstructured":"Filipsson K, Torn\u00f8e K, Holst J, Ahr\u00e9n B (1997) Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans*. J Clin Endocrinol Metab 82(9):3093\u20133098","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"893_CR67","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1210\/endo.140.12.7208","volume":"140","author":"P Borboni","year":"1999","unstructured":"Borboni P, Porzio O, Pierucci D, Cicconi S, Magnaterra R, Federici M, Sesti G, Lauro D, D Agata V, Cavallaro S, LNJL M (1999) Molecular and functional characterization of pituitary adenylate cyclase-activating polypeptide (PACAP-38)\/vasoactive intestinal polypeptide receptors in pancreatic \u03b2-cells and effects of PACAP-38 on components of the insulin secretory System1. Endocrinology 140(12):5530\u20135537","journal-title":"Endocrinology"},{"issue":"1","key":"893_CR68","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/endo-127-1-272","volume":"127","author":"PE Gottschall","year":"1990","unstructured":"Gottschall PE, Tatsuno I, Miyata A, Arimura A (1990) Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide*. Endocrinology 127(1):272\u2013277","journal-title":"Endocrinology"},{"issue":"2","key":"893_CR69","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0196-9781(99)00202-8","volume":"21","author":"R Busto","year":"2000","unstructured":"Busto R, Prieto JC, Bodega G, Zapatero J, Carrero I (2000) Immunohistochemical localization and distribution of VIP\/PACAP receptors in human lung. Peptides 21(2):265\u2013269 \n                    https:\/\/doi.org\/10.1016\/S0196-9781(99)00202-8","journal-title":"Peptides"},{"issue":"1","key":"893_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1749-6632.1998.tb11173.x","volume":"865","author":"N Zeng","year":"1998","unstructured":"Zeng N, Kang TAO, Lyu RM, Wong H, Wen YI, Walsh John H, Sachs G, Pisegna Joseph R (1998) The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR. Ann N Y Acad Sci 865(1):147\u2013156. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb11173.x","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"893_CR71","doi-asserted-by":"publisher","first-page":"R1562","DOI":"10.1152\/ajpregu.2001.281.5.R1562","volume":"281","author":"Y Fukushima","year":"2001","unstructured":"Fukushima Y, Hikichi H, Mizukami K, Nagayama T, Yoshida M, Suzuki-Kusaba M, Hisa H, Kimura T, Satoh S (2001) Role of endogenous PACAP in catecholamine secretion from the rat adrenal gland. Am J Phys Regul Integr Comp Phys 281(5):R1562\u2013R1567. \n                    https:\/\/doi.org\/10.1152\/ajpregu.2001.281.5.R1562","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"3","key":"893_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1530\/JOE-14-0316","volume":"222","author":"A Dian\u00e9","year":"2014","unstructured":"Dian\u00e9 A, Nikolic N, Rudecki AP, King SM, Bowie DJ, Gray SL (2014) PACAP is essential for the adaptive thermogenic response of brown adipose tissue to cold exposure. J Endocrinol 222(3):327\u2013339. \n                    https:\/\/doi.org\/10.1530\/joe-14-0316","journal-title":"J Endocrinol"},{"issue":"10","key":"893_CR73","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1210\/mend.15.10.0705","volume":"15","author":"SL Gray","year":"2001","unstructured":"Gray SL, Cummings KJ, Jirik FR, Sherwood NM (2001) Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15(10):1739\u20131747","journal-title":"Mol Endocrinol"},{"issue":"1","key":"893_CR74","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1073\/pnas.012608999","volume":"99","author":"C Hamelink","year":"2002","unstructured":"Hamelink C, Tjurmina O, Damadzic R, Young WS, Weihe E, Lee H-W, Eiden LE (2002) Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci 99(1):461\u2013466. \n                    https:\/\/doi.org\/10.1073\/pnas.012608999","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"893_CR75","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1172\/JCI9387","volume":"105","author":"F Jamen","year":"2000","unstructured":"Jamen F, Persson K, Bertrand G, Rodriguez-Henche N, Puech R, Bockaert J, Ahr\u00e9n B, Brabet P (2000) PAC1 receptor\u2013deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Investig 105(9):1307\u20131315","journal-title":"J Clin Investig"},{"issue":"2","key":"893_CR76","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000127113","volume":"64","author":"B Lutz-Bucher","year":"1996","unstructured":"Lutz-Bucher B, Monnier D, Koch B (1996) Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and Neurohypophyseal hormone secretion. Neuroendocrinology 64(2):153\u2013161","journal-title":"Neuroendocrinology"},{"issue":"4","key":"893_CR77","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1681\/ASN.2006060633","volume":"18","author":"M Hautmann","year":"2007","unstructured":"Hautmann M, Friis UG, Desch M, Todorov V, Castrop H, Segerer F, Otto C, Sch\u00fctz G, Schweda F (2007) Pituitary adenylate cyclase\u2013activating polypeptide stimulates renin secretion via activation of PAC1 receptors. J Am Soc Nephrol 18(4):1150\u20131156. \n                    https:\/\/doi.org\/10.1681\/asn.2006060633","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"893_CR78","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/ijc.23308","volume":"122","author":"N Nemetz","year":"2008","unstructured":"Nemetz N, Abad C, Lawson G, Nobuta H, Chhith S, Duong L, Tse G, Braun J, Waschek JA (2008) Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP. Int J Cancer 122(8):1803\u20131809. \n                    https:\/\/doi.org\/10.1002\/ijc.23308","journal-title":"Int J Cancer"},{"issue":"3","key":"893_CR79","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF03033976","volume":"8","author":"N Babai","year":"2005","unstructured":"Babai N, Atlasz T, Tam\u00e1s A, Reglodi D, T\u00f3th G, Kiss P, G\u00e1briel R (2005) Degree of damage compensation by various pacap treatments in monosodium glutamate-induced retinal degeneration. Neurotox Res 8(3):227\u2013233. \n                    https:\/\/doi.org\/10.1007\/bf03033976","journal-title":"Neurotox Res"},{"issue":"1","key":"893_CR80","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.regpep.2006.06.016","volume":"137","author":"Y Chen","year":"2006","unstructured":"Chen Y, Samal B, Hamelink CR, Xiang CC, Chen Y, Chen M, Vaudry D, Brownstein MJ, Hallenbeck JM, Eiden LE (2006) Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept 137(1):4\u201319 \n                    https:\/\/doi.org\/10.1016\/j.regpep.2006.06.016","journal-title":"Regul Pept"},{"issue":"6","key":"893_CR81","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.peptides.2011.04.003","volume":"32","author":"A Dejda","year":"2011","unstructured":"Dejda A, Seaborn T, Bourgault S, Touzani O, Fournier A, Vaudry H, Vaudry D (2011) PACAP and a novel stable analog protect rat brain from ischemia: insight into the mechanisms of action. Peptides 32(6):1207\u20131216 \n                    https:\/\/doi.org\/10.1016\/j.peptides.2011.04.003","journal-title":"Peptides"},{"issue":"4","key":"893_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1556\/ABiol.65.2014.4.1","volume":"65","author":"E L\u00e1szl\u00f3","year":"2014","unstructured":"L\u00e1szl\u00f3 E, Kiss P, Horv\u00e1th G, Szak\u00e1ly P, Tam\u00e1s A, Regl\u00f6di D (2014) The effects of pituitary adenylate cyclase activating polypeptide in renal ischemia\/reperfusion. Acta Biol Hung 65(4):369\u2013378. \n                    https:\/\/doi.org\/10.1556\/ABiol.65.2014.4.1","journal-title":"Acta Biol Hung"},{"issue":"3","key":"893_CR83","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12031-012-9818-1","volume":"48","author":"P Lazarovici","year":"2012","unstructured":"Lazarovici P, Cohen G, Arien-Zakay H, Chen J, Zhang C, Chopp M, Jiang H (2012) Multimodal neuroprotection induced by PACAP38 in oxygen\u2013glucose deprivation and middle cerebral artery occlusion stroke models. J Mol Neurosci 48(3):526\u2013540. \n                    https:\/\/doi.org\/10.1007\/s12031-012-9818-1","journal-title":"J Mol Neurosci"},{"key":"893_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2016.10.046","volume":"340","author":"M Muzzi","year":"2017","unstructured":"Muzzi M, Buonvicino D, De Cesaris F, Chiarugi A (2017) Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury. Neuroscience 340:1\u20137. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2016.10.046","journal-title":"Neuroscience"},{"issue":"19","key":"893_CR85","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.1073\/pnas.0600375103","volume":"103","author":"H Ohtaki","year":"2006","unstructured":"Ohtaki H, Nakamachi T, Dohi K, Aizawa Y, Takaki A, Hodoyama K, Yofu S, Hashimoto H, Shintani N, Baba A, Kopf M, Iwakura Y, Matsuda K, Arimura A, Shioda S (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci 103(19):7488\u20137493. \n                    https:\/\/doi.org\/10.1073\/pnas.0600375103","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"893_CR86","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1161\/01.STR.31.6.1411","volume":"31","author":"D Reglodi","year":"2000","unstructured":"Reglodi D, Somogyvari-Vigh A, Vigh S, Kozicz T, Arimura A (2000) Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 31(6):1411\u20131417. \n                    https:\/\/doi.org\/10.1161\/01.str.31.6.1411","journal-title":"Stroke"},{"issue":"12","key":"893_CR87","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/S0196-9781(02)00262-0","volume":"23","author":"D Reglodi","year":"2002","unstructured":"Reglodi D, Tam\u00e1s A, Somogyv\u00e1ri-Vigh A, Sz\u00e1nt\u00f3 Z, Kertes E, L\u00e9n\u00e1rd L, Arimura A, Lengv\u00e1ri I (2002) Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides 23(12):2227\u20132234 \n                    https:\/\/doi.org\/10.1016\/S0196-9781(02)00262-0","journal-title":"Peptides"},{"issue":"2","key":"893_CR88","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12031-016-0818-4","volume":"60","author":"A Vaczy","year":"2016","unstructured":"Vaczy A, Reglodi D, Somoskeoy T, Kovacs K, Lokos E, Szabo E, Tamas A, Atlasz T (2016) The protective role of PAC1-receptor agonist Maxadilan in BCCAO-induced retinal degeneration. J Mol Neurosci 60(2):186\u2013194. \n                    https:\/\/doi.org\/10.1007\/s12031-016-0818-4","journal-title":"J Mol Neurosci"},{"issue":"1","key":"893_CR89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s10194-018-0845-3","volume":"19","author":"D Reglodi","year":"2018","unstructured":"Reglodi D, Vaczy A, Rubio-Beltran E, MaassenVanDenBrink A (2018) Protective effects of PACAP in ischemia. J Headache Pain 19(1):19. \n                    https:\/\/doi.org\/10.1186\/s10194-018-0845-3","journal-title":"J Headache Pain"},{"issue":"10","key":"893_CR90","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1002\/art.38772","volume":"66","author":"B Botz","year":"2014","unstructured":"Botz B, B\u00f6lcskei K, Kereskai L, Kov\u00e1cs M, N\u00e9meth T, Szigeti K, Horv\u00e1th I, M\u00e1th\u00e9 D, Kov\u00e1cs N, Hashimoto H, Regl\u0151di D, Szolcs\u00e1nyi J, Pint\u00e9r E, M\u00f3csai A, Helyes Z (2014) Differential regulatory role of pituitary adenylate cyclase\u2013activating polypeptide in the serum-transfer arthritis model. Arthritis Rheumatol 66(10):2739\u20132750. \n                    https:\/\/doi.org\/10.1002\/art.38772","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"893_CR91","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1476-5381.1992.tb14336.x","volume":"106","author":"JB Warren","year":"1992","unstructured":"Warren JB, Larkin SW, Coughlan M, Kajekar R, Williams TJ (1992) Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo. Br J Pharmacol 106(2):331\u2013334. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.1992.tb14336.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"893_CR92","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.mvr.2011.10.003","volume":"83","author":"E Svensj\u00f6","year":"2012","unstructured":"Svensj\u00f6 E, Saraiva EM, Amendola RS, Barja-Fidalgo C, Bozza MT, Lerner EA, Teixeira MM, Scharfstein J (2012) Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1\u2013CXCR1\/2-pathway. Microvasc Res 83(2):185\u2013193 \n                    https:\/\/doi.org\/10.1016\/j.mvr.2011.10.003","journal-title":"Microvasc Res"},{"issue":"9","key":"893_CR93","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.peptides.2007.06.029","volume":"28","author":"J Watanabe","year":"2007","unstructured":"Watanabe J, Nakamachi T, Matsuno R, Hayashi D, Nakamura M, Kikuyama S, Nakajo S, Shioda S (2007) Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development. Peptides 28(9):1713\u20131719 \n                    https:\/\/doi.org\/10.1016\/j.peptides.2007.06.029","journal-title":"Peptides"},{"issue":"1","key":"893_CR94","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.yfrne.2007.10.001","volume":"29","author":"H Ghzili","year":"2008","unstructured":"Ghzili H, Grumolato L, Thou\u00ebnnon E, Tanguy Y, Turquier V, Vaudry H, Anouar Y (2008) Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol 29(1):128\u2013141 \n                    https:\/\/doi.org\/10.1016\/j.yfrne.2007.10.001","journal-title":"Front Neuroendocrinol"},{"key":"893_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.psyneuen.2014.03.007","volume":"45","author":"KR Lezak","year":"2014","unstructured":"Lezak KR, Roelke E, Harris OM, Choi I, Edwards S, Gick N, Cocchiaro G, Missig G, Roman CW, Braas KM, Toufexis DJ, May V, Hammack SE (2014) Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats. Psychoneuroendocrinology 45:11\u201320 \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2014.03.007","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"893_CR96","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/10253890.2017.1336535","volume":"20","author":"SB King","year":"2017","unstructured":"King SB, Toufexis DJ, Hammack SE (2017) Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones. Stress 20(5):465\u2013475. \n                    https:\/\/doi.org\/10.1080\/10253890.2017.1336535","journal-title":"Stress"},{"key":"893_CR97","doi-asserted-by":"publisher","unstructured":"Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm SD, Kilaru V, Smith AK, Myers AJ, Ramirez M, Engel A, Hammack SE, Toufexis D, Braas KM, Binder EB, May V (2011) Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470:492. \n                    https:\/\/doi.org\/10.1038\/nature09856","DOI":"10.1038\/nature09856"},{"issue":"4","key":"893_CR98","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2174\/1871527314666150429114234","volume":"14","author":"J Tajti","year":"2015","unstructured":"Tajti J, Tuka B, Botz B, Helyes Z, Vecsei L (2015) Role of pituitary adenylate cyclase-activating polypeptide in nociception and migraine. CNS Neurol Disord Drug Targets 14(4):540\u2013553 \n                    https:\/\/doi.org\/10.2174\/1871527314666150429114234","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"893_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pain.2008.10.028","volume":"141","author":"K S\u00e1ndor","year":"2009","unstructured":"S\u00e1ndor K, B\u00f6lcskei K, McDougall JJ, Schuelert N, Reglodi D, Elekes K, Petho G, Pint\u00e9r E, Szolcs\u00e1nyi J, Helyes Z (2009) Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Pain 141(1):143\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.pain.2008.10.028","journal-title":"Pain"},{"issue":"1","key":"893_CR100","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-018-0861-3","volume":"19","author":"FM Amin","year":"2018","unstructured":"Amin FM, Schytz HW (2018) Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine. J Headache Pain 19(1):35. \n                    https:\/\/doi.org\/10.1186\/s10194-018-0861-3","journal-title":"J Headache Pain"},{"issue":"1","key":"893_CR101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10194-018-0852-4","volume":"19","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Tajti J, Szal\u00e1rdy L, V\u00e9csei L (2018) PACAP and its role in primary headaches. J Headache Pain 19(1):21. \n                    https:\/\/doi.org\/10.1186\/s10194-018-0852-4","journal-title":"J Headache Pain"},{"issue":"S2","key":"893_CR102","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/head.13076","volume":"57","author":"ALH Vollesen","year":"2017","unstructured":"Vollesen ALH, Ashina M (2017) PACAP38: emerging drug target in migraine and cluster headache. Headache: J Head Face Pain 57(S2):56\u201363. \n                    https:\/\/doi.org\/10.1111\/head.13076","journal-title":"Headache: J Head Face Pain"},{"issue":"1","key":"893_CR103","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10194-016-0705-y","volume":"17","author":"E Bacchelli","year":"2016","unstructured":"Bacchelli E, Cainazzo MM, Cameli C, Guerzoni S, Martinelli A, Zoli M, Maestrini E, Pini LA (2016) A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants. J Headache Pain 17(1):114. \n                    https:\/\/doi.org\/10.1186\/s10194-016-0705-y","journal-title":"J Headache Pain"},{"key":"893_CR104","unstructured":"Guo S, Petersen AS, Schytz HW, Barl\u00f8se M, Caparso A, Fahrenkrug J, Jensen RH, Ashina M (2017) Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks. Cephalalgia 38 (8):1418-1428"},{"issue":"13","key":"893_CR105","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0333102413483931","volume":"33","author":"B Tuka","year":"2013","unstructured":"Tuka B, Helyes Z, Markovics A, Bagoly T, Szolcs\u00e1nyi J, Szab\u00f3 N, T\u00f3th E, Kincses ZT, V\u00e9csei L, Tajti J (2013) Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia 33(13):1085\u20131095. \n                    https:\/\/doi.org\/10.1177\/0333102413483931","journal-title":"Cephalalgia"},{"issue":"1","key":"893_CR106","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10194-016-0660-7","volume":"17","author":"B Tuka","year":"2016","unstructured":"Tuka B, Szab\u00f3 N, T\u00f3th E, Kincses ZT, P\u00e1rdutz \u00c1, Szok D, K\u00f6rt\u00e9si T, Bagoly T, Helyes Z, Edvinsson L, V\u00e9csei L, Tajti J (2016) Release of PACAP-38 in episodic cluster headache patients \u2013 an exploratory study. J Headache Pain 17(1):69. \n                    https:\/\/doi.org\/10.1186\/s10194-016-0660-7","journal-title":"J Headache Pain"},{"key":"893_CR107","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13578-016-0106-6","volume":"6","author":"L Hou","year":"2016","unstructured":"Hou L, Wan D, Dong Z, Tang W, Han X, Li L, Yang F, Yu S (2016) Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs. Cell Biosci 6:40. \n                    https:\/\/doi.org\/10.1186\/s13578-016-0106-6","journal-title":"Cell Biosci"},{"issue":"12","key":"893_CR108","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/acn3.113","volume":"1","author":"AS Zagami","year":"2014","unstructured":"Zagami AS, Edvinsson L, Goadsby PJ (2014) Pituitary adenylate cyclase activating polypeptide and migraine. Ann Clin Transl Neurol 1(12):1036\u20131040. \n                    https:\/\/doi.org\/10.1002\/acn3.113","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"893_CR109","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132(1):16\u201325. \n                    https:\/\/doi.org\/10.1093\/brain\/awn307","journal-title":"Brain"},{"key":"893_CR110","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","volume":"13","author":"M Ashina","year":"2017","unstructured":"Ashina M, Hansen JM, \u00e1 Dunga BO, Olesen J (2017) Human models of migraine \u2014 short-term pain for long-term gain. Nat Rev Neurol 13:713. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.137","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"893_CR111","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1460-9568.2006.05036.x","volume":"24","author":"A Bergerot","year":"2006","unstructured":"Bergerot A, Holland PR, Akerman S, Bartsch T, Ahn AH, MaassenVanDenBrink A, Reuter U, Tassorelli C, Schoenen J, Mitsikostas DD, VanDenMaagdenberg AMJM, Goadsby PJ (2006) Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci 24(6):1517\u20131534. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05036.x","journal-title":"Eur J Neurosci"},{"issue":"3","key":"893_CR112","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.regpep.2006.12.010","volume":"140","author":"S Birk","year":"2007","unstructured":"Birk S, Sitarz JT, Petersen KA, Oturai PS, Kruuse C, Fahrenkrug J, Olesen J (2007) The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers. Regul Pept 140(3):185\u2013191 \n                    https:\/\/doi.org\/10.1016\/j.regpep.2006.12.010","journal-title":"Regul Pept"},{"issue":"2","key":"893_CR113","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/0333102411431333","volume":"32","author":"FM Amin","year":"2012","unstructured":"Amin FM, Asghar MS, Guo S, Hougaard A, Hansen AE, Schytz HW, RJvd G, de PJH K, HBW L, Olesen J, Ashina M (2012) Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. Cephalalgia 32(2):140\u2013149. \n                    https:\/\/doi.org\/10.1177\/0333102411431333","journal-title":"Cephalalgia"},{"issue":"3","key":"893_CR114","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","volume":"137","author":"FM Amin","year":"2014","unstructured":"Amin FM, Hougaard A, Schytz HW, Asghar MS, Lundholm E, Parvaiz AI, de Koning PJH, Andersen MR, Larsson HBW, Fahrenkrug J, Olesen J, Ashina M (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 137(3):779\u2013794. \n                    https:\/\/doi.org\/10.1093\/brain\/awt369","journal-title":"Brain"},{"issue":"2","key":"893_CR115","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0333102410375624","volume":"31","author":"KY Chan","year":"2011","unstructured":"Chan KY, Baun M, de Vries R, van den Bogaerdt AJ, Dirven CM, Danser AH, Jansen-Olesen I, Olesen J, Villalon CM, MaassenVanDenBrink A, Gupta S (2011) Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 31(2):181\u2013189. \n                    https:\/\/doi.org\/10.1177\/0333102410375624","journal-title":"Cephalalgia"},{"issue":"2","key":"893_CR116","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1212\/WNL.0000000000002261","volume":"86","author":"FM Amin","year":"2016","unstructured":"Amin FM, Hougaard A, Magon S, Asghar MS, Ahmad NN, Rostrup E, Sprenger T, Ashina M (2016) Change in brain network connectivity during PACAP38-induced migraine attacks A resting-state functional MRI study. Neurology 86(2):180\u2013187. \n                    https:\/\/doi.org\/10.1212\/wnl.0000000000002261","journal-title":"Neurology"},{"issue":"12","key":"893_CR117","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","volume":"157","author":"S Guo","year":"2016","unstructured":"Guo S, Vollesen ALH, Olesen J, Ashina M (2016) Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine. Pain 157(12):2773\u20132781. \n                    https:\/\/doi.org\/10.1097\/j.pain.0000000000000702","journal-title":"Pain"},{"issue":"2","key":"893_CR118","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0333102416639517","volume":"37","author":"S Guo","year":"2017","unstructured":"Guo S, Vollesen ALH, Hansen YBL, Frandsen E, Andersen MR, Amin FM, Fahrenkrug J, Olesen J, Ashina M (2017) Part II: biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients. Cephalalgia 37(2):136\u2013147. \n                    https:\/\/doi.org\/10.1177\/0333102416639517","journal-title":"Cephalalgia"},{"issue":"6","key":"893_CR119","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/0969-8051(94)90166-X","volume":"21","author":"M Hassan","year":"1994","unstructured":"Hassan M, Refai E, Andersson M, Schnell P-O, Jacobsson H (1994) In vivo dynamical distribution of 131I-VIP in the rat studied by gamma-camera. Nucl Med Biol 21(6):865\u2013872. \n                    https:\/\/doi.org\/10.1016\/0969-8051(94)90166-X","journal-title":"Nucl Med Biol"},{"issue":"8","key":"893_CR120","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1468-2982.2008.01807.x","volume":"29","author":"LJ Boni","year":"2009","unstructured":"Boni LJ, Ploug KB, Olesen I, Jansen-Olesen I, Gupta S (2009) The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery. Cephalalgia 29(8):837\u2013847. \n                    https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01807.x","journal-title":"Cephalalgia"},{"issue":"308","key":"893_CR121","doi-asserted-by":"publisher","first-page":"308ra157","DOI":"10.1126\/scitranslmed.aaa7557","volume":"7","author":"S Akerman","year":"2015","unstructured":"Akerman S, Goadsby PJ (2015) Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: relevance to migraine. Sci Transl Med 7(308):308ra157. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aaa7557","journal-title":"Sci Transl Med"},{"key":"893_CR122","doi-asserted-by":"crossref","unstructured":"Han X, Ran Y, Su M, Liu Y, Tang W, Dong Z, Yu S (2017) Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats. Mol Pain 13:1\u201310","DOI":"10.1177\/1744806917720361"},{"issue":"1S","key":"893_CR123","first-page":"141","volume":"36","author":"J Hoffmann","year":"2016","unstructured":"Hoffmann J, Martins-Oliveira M, Akerman S, Supronsinchai W, Xu C, Goadsby PJ (2016) PAC-1 receptor antibody modulates nociceptive trigeminal activity in rat. Cephalalgia 36(1S):141\u2013141","journal-title":"Cephalalgia"},{"issue":"4","key":"893_CR124","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0333102412439354","volume":"32","author":"M Baun","year":"2012","unstructured":"Baun M, Pedersen MHF, Olesen J, Jansen-Olesen I (2012) Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 32(4):337\u2013345. \n                    https:\/\/doi.org\/10.1177\/0333102412439354","journal-title":"Cephalalgia"},{"issue":"11","key":"893_CR125","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0333102414523846","volume":"34","author":"DK Bhatt","year":"2014","unstructured":"Bhatt DK, Gupta S, Olesen J, Jansen-Olesen I (2014) PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells. Cephalalgia 34(11):877\u2013886. \n                    https:\/\/doi.org\/10.1177\/0333102414523846","journal-title":"Cephalalgia"},{"issue":"3","key":"893_CR126","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1468-2982.1997.1703166.x","volume":"17","author":"A Ottosson","year":"1997","unstructured":"Ottosson A, Edvinsson L (1997) Release of histamine from Dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 17(3):166\u2013174. \n                    https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1703166.x","journal-title":"Cephalalgia"},{"key":"893_CR127","unstructured":"Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention. \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03238781\n                    \n                  . Accessed 02 May 2018."},{"key":"893_CR128","unstructured":"ALD1910 \u2013 migraine prevention.\u00a0\n                    alderbio.com\n                    \n                  . \n                    https:\/\/www.alderbio.com\/pipeline\/ald1910\/\n                    \n                  . Accessed 19 May 2018."},{"issue":"5","key":"893_CR129","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1189\/jlb.0704432","volume":"77","author":"C Mart\u00ednez","year":"2005","unstructured":"Mart\u00ednez C, Juarranz Y, Abad C, Arranz A, Miguel BG, Rosignoli F, Leceta J, Gomariz RP (2005) Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock. J Leukoc Biol 77(5):729\u2013738. \n                    https:\/\/doi.org\/10.1189\/jlb.0704432","journal-title":"J Leukoc Biol"},{"issue":"7175","key":"893_CR130","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.318.7175.13","volume":"318","author":"CL Chang","year":"1999","unstructured":"Chang CL, Donaghy M, Poulter N (1999) Migraine and stroke in young women: case-control study. BMJ : Br Med J 318(7175):13\u201318. \n                    https:\/\/doi.org\/10.1136\/bmj.318.7175.13","journal-title":"BMJ : Br Med J"},{"issue":"7482","key":"893_CR131","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/bmj.38302.504063.8F","volume":"330","author":"M Etminan","year":"2005","unstructured":"Etminan M, Takkouche B, Isorna FC, Samii A (2005) Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ : Br Med J 330(7482):63\u201363. \n                    https:\/\/doi.org\/10.1136\/bmj.38302.504063.8F","journal-title":"BMJ : Br Med J"},{"key":"893_CR132","doi-asserted-by":"publisher","first-page":"b3914","DOI":"10.1136\/bmj.b3914","volume":"339","author":"M Schurks","year":"2009","unstructured":"Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T (2009) Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ: Br Med J 339:b3914","journal-title":"BMJ: Br Med J"},{"issue":"7","key":"893_CR133","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.amjmed.2009.12.021","volume":"123","author":"JT Spector","year":"2010","unstructured":"Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S (2010) Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 123(7):612\u2013624. \n                    https:\/\/doi.org\/10.1016\/j.amjmed.2009.12.021","journal-title":"Am J Med"},{"issue":"1","key":"893_CR134","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-017-0807-1","volume":"18","author":"M Deen","year":"2017","unstructured":"Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltran E, Vigneri S, Edvinsson L, Maassen Van Den Brink A, European Headache Federation School of Advanced S (2017) Blocking CGRP in migraine patients - a review of pros and cons. J Headache Pain 18(1):96. \n                    https:\/\/doi.org\/10.1186\/s10194-017-0807-1","journal-title":"J Headache Pain"},{"issue":"9","key":"893_CR135","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.tips.2016.06.002","volume":"37","author":"A MaassenVanDenBrink","year":"2016","unstructured":"MaassenVanDenBrink A, Meijer J, Villal\u00f3n CM, Ferrari MD (2016) Wiping out CGRP: potential cardiovascular risks. Trends Pharmacol Sci 37(9):779\u2013788. \n                    https:\/\/doi.org\/10.1016\/j.tips.2016.06.002","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"893_CR136","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/WCO.0000000000000438","volume":"30","author":"DD Mitsikostas","year":"2017","unstructured":"Mitsikostas DD, Reuter U (2017) Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies. Curr Opin Neurol 30(3):272\u2013280. \n                    https:\/\/doi.org\/10.1097\/wco.0000000000000438","journal-title":"Curr Opin Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-018-0893-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-018-0893-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-018-0893-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T23:03:20Z","timestamp":1565132600000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-018-0893-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1186\/s10194-018-0893-8","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AMvdB received research grants and\/or consultation fees from Amgen\/Novartis, Lilly\/CoLucid, Teva and ATI. LE has given talks and received grant for preclinical studies sponsored by Novartis and TEVA. All other authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"64"}}